IP Library › Granted Patent US 12,576,062
Granted Patent B2
US 12,576,062 · App. 17/440,021 · Granted Mar 17, 2026

Methods using administration of medium chain triglycerides (MCT) prior to a meal to increase ketone production from the MCTs

Inventor: Bernard Cuenoud (Cully, CH)
Assignee: Societe des Produits Nestle S.A.
A61K31/23A61K9/0053A61P3/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,576,062
App. No.
17/440,021
Granted
Mar 17, 2026
Kind
B2
Abstract

A method increases production of ketones derived from oral consumption of medium chain triglycerides (MCT) by an individual. The method includes orally administering to the individual a composition containing the MCTs and then subsequently orally administering to the individual a meal at least about ten minutes after the oral administration of the composition containing the MCTs and within about one hour of the oral administration of the composition containing the MCTs. For example, the meal can be administered about thirty minutes after the administration of the composition containing the MCTs. The ketone production is increased relative to ketone production from oral administration of the MCTs and the meal at approximately the same time. The meal can be breakfast. The composition containing the MCTs can be a liquid oral nutritional supplement (ONS) providing incomplete nutrition.

Claims (23)

1 . A method of increasing production of ketones derived from oral consumption of medium chain triglycerides (MCT) by an individual, the method comprising:

orally administering to the individual a composition comprising the MCTs; and

subsequently orally administering to the individual a meal after the orally administering the composition comprising the MCTs, wherein the meal is administered at least about fifteen minutes after the orally administering the composition comprising the MCTs and within about forty minutes after the orally administering the composition comprising the MCTs;

wherein the composition is administered to the individual in a serving comprising about 15.0 g of the MCTs and the composition comprises the MCTs emulsified in at least one additional component selected from the group consisting of a protein, a lipid, a carbohydrate, and an emulsifier.

2 . The method of claim 1 , wherein the individual is elderly.

3 . The method of claim 1 , wherein the composition comprising the MCTs is a liquid.

4 . The method of claim 1 , wherein the meal is administered about thirty minutes after the orally administering the composition comprising the MCTs.

5 . The method of claim 1 , wherein the meal is breakfast.

6 . The method of claim 1 , wherein at least a portion of the MCTs comprises at least one of octanoic acid or decanoic acid.

7 . The method of claim 1 , wherein at least a portion of the ketones are selected from the group consisting of β-hydroxy butyrate, acetone-acetate and mixtures thereof.

8 . The method of claim 1 , wherein the production of the ketones in the individual is increased relative to ketone production from orally administering the composition comprising the MCTs and the meal to the individual at approximately the same time.

9 . The method of claim 1 , wherein the composition is a liquid incomplete nutrition oral nutritional supplement (ONS).

10 . The method of claim 1 , wherein the individual does not consume any food products other than optional water during a time period starting at the orally administering the composition comprising the MCTs to the individual and ending at the orally administering the meal to the individual.

11 . A method of treating a condition for which increased production of ketones from medium chain triglycerides (MCTs) is beneficial, wherein the condition is a neurological condition or a brain energy deficiency condition selected from the group consisting of a migraine, a memory disorder, an age-related memory disorder, a brain injury, a stroke, amyotrophic lateral sclerosis, multiple sclerosis, cognitive impairment, cognitive impairment post-intensive care, age-induced cognition impairment, Alzheimer's disease, Parkinson's disease, Huntington's disease, an inherited metabolic disorder, bipolar disorder, schizophrenia, epilepsy, and combinations thereof, the method comprising:

orally administering, to an individual having the condition or at risk of the condition, a composition comprising the MCTs in a serving or unit dosage form that provides a therapeutically effective amount of the MCTs and/or provides an amount of the MCTs metabolized into a therapeutically effective amount of ketones;

wherein a meal is administered at least about fifteen minutes after the orally administering the composition comprising the MCTs and within about forty minutes after the orally administering the composition comprising the MCTs; and

wherein the composition is administered to the individual in a serving comprising about 15.0 g of the MCTs and the composition comprises the MCTs emulsified in at least one additional component selected from the group consisting of a protein, a lipid, a carbohydrate, and an emulsifier.

12 . The method of claim 11 , wherein the meal is administered about thirty minutes after the orally administering the composition comprising the MCTs.

13 . A method of improving or maintaining at least one of neurologic health, cognitive function, or exercise performance in an individual in need thereof, the method comprising:

orally administering to the individual a composition comprising medium chain triglycerides (MCTs); and

wherein a meal is administered at least about fifteen minutes after the orally administering the composition comprising the MCTs and within about forty minutes after the orally administering the composition comprising the MCTs;

wherein the composition is administered to the individual in a serving comprising about 15.0 g of the MCTs and the composition comprises the MCTs emulsified in at least one additional component selected from the group consisting of a protein, a lipid, a carbohydrate, and an emulsifier.

14 . The method of claim 13 , wherein the meal is administered about thirty minutes after the orally administering the composition comprising the MCTs.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2022
From: CUENOUD, BERNARD
To: NESTEC S.A.
Reel/Frame 059476/0859 →
MERGER Recorded Apr 1, 2022
From: NESTEC S.A.
To: SOCIETE DES PRODUITS NESTLE S.A.
Reel/Frame 059477/0093 →
Continuity (2)
Provisional Application 62822299 · Mar 22, 2019
Related Publication 20220168256A1 · Jun 2, 2022
References Cited (40)
US 11000496B2 · Cuenoud · 2021 [cited by examiner]
US 20040071751A1 · Maki et al. · 2004 [cited by applicant]
US 20040076719A1 · Pimentel · 2004 [cited by applicant]
US 20070179197A1 · Henderson · 2007 [cited by applicant]
CN 107921133A · 2018 [cited by applicant]
CN 108348496A · 2018 [cited by applicant]
CN 109069465A · 2018 [cited by applicant]
CN 110800904 · 2020 [cited by applicant]
CN 113194733A · 2021 [cited by applicant]
GB 2568791 · 2019 [cited by applicant]
JP 2009524587A · 2009 [cited by applicant]
WO 2009118968 · 2009 [cited by applicant]
WO 2014153416 · 2014 [cited by applicant]
WO 2018102914A1 · 2018 [cited by applicant]
WO 2018115158 · 2018 [cited by applicant]
Courchesne-Loyer et al. “Emulsification increases the acute ketogenic effect and bioavailability of medium-chain triglycerides in humans” Current Developments in Nutrition, Jul. 1, 2017, vol. 1, No. 7, p. 1-32 (Year: 20… [cited by examiner]
Rolls et al. “Food intake in dieters and nondieters after a liquid meal containing medium-chain triglycerides” Am J Clin Nutr, 1988, vol. 48, pp. 66-71 (Year: 1988). [cited by examiner]
Ota et al. “Effect of a ketogenic meal on cognitive function in elderly adults: potential for cognitive enhancement” Psychopharmacology, 2016, vol. 233, pp. 3797-3802 (Year: 2016). [cited by examiner]
Vandenberghe et al., “Tricaprylin Alone Increases Plasma Ketone Response More Than Coconut Oil or Other Medium-Chain Triglycerides: An Acute Crossover Study in Healthy Adults”, Current Developments in Nutrition, 2017, v… [cited by examiner]
Strong First Forum, “MCT Oil: Best for Weight Loss”, StrongFirst, Mar. 4, 2018, 19 pages (Year: 2018). [cited by examiner]
Friedman et al., “Fuel partitioning and food intake: role for mitochondrial fatty acid transport”, American Physiological Society, 1990, vol. 258, R216-R221 (Year: 1990). [cited by examiner]
Phillips et al., “Spina Bifida Management”, 2017, 47, pp. 173-177Curr Probl Pediatr Adolesc Health Care, 47, pp. 173-177 (Year: 2017). [cited by examiner]
Phillips et al., “Spina Bifida Management”, 2017, Curr Probl Pediatr Adolesc Health Care, 47, pp. 173-177 (Year: 2017). [cited by examiner]
Gulati et al., “Cerebral Palsy: An Overview”, 2018, Indian J Pediatr, 85, pp. 1006-1016 (Year: 2018). [cited by examiner]
De Strooper et al., “The Cellular Phase of Alzheimer's Disease”, 2016, Cell, 164, pp. 603-615 (Year: 2016). [cited by examiner]
Scheltens et al., “Alzheimer's disease”, 2016, The Lancet, 388, pp. 505-517 (Year: 2016). [cited by examiner]
Chinese Office Action for Chinese Appl No. 202080017340.9 dated Apr. 24, 2024, 8 pages. [cited by applicant]
Chinese Office Action for Appl No. 202080017340.9 dated Jul. 19, 2023. [cited by applicant]
St-Onge et al. “Impact of medium and long chain triglycerides consumption on appetite and food intake in overweight men” European Journal of Clinical Nutrition, 2014, vol. 68, pp. 1134-1140. [cited by applicant]
Courchesne-Loyer et al. “Emulsification increases the acute ketogenic effect and bioavailability of medium-chain triglycerides in humans” Current Developments in Nutrition, Jul. 1, 2017, vol. 1, No. 7, 32 pages, XP55621… [cited by applicant]
Otto et al. “Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides” BMC Cancer, 2008, vol. 8, No. 122, 12 pages. [cited by applicant]
Iemitsu et al. “The benefit of medium-chain triglyceride therapy on the cardiac function of SHRs is associated with a reversal of metabolic and signaling alterations” Am J Physiol Heart Circ Physiol, 2008, vol. 295, pp.… [cited by applicant]
Maggio et al. “Food Intake After Intragastric Meals of Short-, Medium-, or Long-Chain Triglyceride” Physiology & Behavior, 1982, vol. 28, pp. 921-926. [cited by applicant]
Rizzo et al. “Coconut and sunflower oil ratios in ice cream influence subsequent food selection and intake” Physiology & Behavior, 2016, vol. 164, pp. 40-46. [cited by applicant]
Rolls et al. “Food intake in dieters and nondieters after a liquid meal containing medium-chain triglycerides” Am J Clin Nutr, 1988, vol. 48, pp. 66-71. [cited by applicant]
Marten et al. “Medium-chain triglycerides” International Dairy Journal, 2006, vol. 16, pp. 1374-1382. [cited by applicant]
Clegg “Medium-chain triglycerides are advantageous in promoting weight loss although not beneficial to exercise performance” International Journal of Food Sciences and Nutrition, 2010, vol. 61, No. 7, pp. 653-679. [cited by applicant]
Kinsella et al. “Coconut oil has less satiating properties than medium chain triglyceride oil” Physiology & Behavior, 2017, vol. 179, pp. 422-426. [cited by applicant]
Ota et al. “Effect of a ketogenic meal on cognitive function in elderly adults: potential for cognitive enhancement” Psychopharmacology, 2016, vol. 233, pp. 3797-3802. [cited by applicant]
Australian Office Action for Appl No. 2020246928 dated Oct. 31, 2024, 6 pages. [cited by applicant]